Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality

Transfusion

Volumn 52, Issue 12, 2012, Pages 2590-2593

  Raval, Jay S ^a   Nelson, Joel B ^a   Woldemichael, Elen ^a   Triulzi, Darrell J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUTOLOGOUS DONATION; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE CELL SALVAGE; LENGTH OF STAY; LONG TERM BIOCHEMICAL RECURRENCE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OPERATION DURATION; ORGAN DONOR; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SALVAGE THERAPY; UROLOGIST;

AGED; BLOOD TRANSFUSION, AUTOLOGOUS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OPERATIVE BLOOD SALVAGE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84870995769     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03682.x     Document Type: Article

References (24)

1. Cooperberg MR, Moul JW, Carroll PR,. The changing face of prostate cancer. J Clin Oncol 2005; 23: 8146-51.
2. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL,. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-48.
3. MacIvor D, Nelson J, Triulzi D,. Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion 2009; 49: 1431-4.
4. Ness PM, Bourke DL, Walsh PC,. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion 1992; 32: 226-30.
5. Monk TG, Goodnough LT, Birkmeyer JD, Brecher ME, Catalona WJ,. Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion 1995; 35: 559-65.
6. Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ,. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91: 24-33.
7. Waters JH, Lee JS, Klein E, O'Hara J, Zippe C, Potter PS,. Preoperative autologous donation versus cell salvage in the avoidance of allogeneic transfusion in patients undergoing radical retropubic prostatectomy. Anesth Analg 2004; 98: 537-42, table of contents.
8. Yawn DH,. Blood salvage for cardiovascular surgery. Perfusion 1990; 5: 31-7.
9. Ley SJ,. Intraoperative and postoperative blood salvage. AACN Clin Issues 1996; 7: 238-48.
10. Waters JH, Dyga RM, Waters JF, Yazer MH,. The volume of returned red blood cells in a large blood salvage program: where does it all go? Transfusion 2011; 51: 2126-32.
11. Waters JH, Biscotti C, Potter PS, Phillipson E,. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000; 92: 1531-6.
12. Chanda A, Smith DR, Nanda A,. Autotransfusion by cell saver technique in surgery of lumbar and thoracic spinal fusion with instrumentation. J Neurosurg 2002; 96: 298-303.
13. Liang TB, Li DL, Liang L, Li JJ, Bai XL, Yu W, Wang WL, Shen Y, Zhang M, Zheng SS,. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation 2008; 85: 863-9.
14. Nieder AM, Manoharan M, Yang Y, Soloway MS,. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007; 69: 881-4.
15. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ,. Intraoperative cell salvage in radical retropubic prostatectomy. Urology 2001; 58: 740-5.
16. Davis M, Sofer M, Gomez-Marin O, Bruck D, Soloway MS,. The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int 2003; 91: 474-6.
17. Nieder AM, Carmack AJ, Sved PD, Kim SS, Manoharan M, Soloway MS,. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology 2005; 65: 730-4.
18. Ubee S, Kumar M, Athmanathan N, Singh G, Vesey S,. Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. Ann R Coll Surg Engl 2011; 93: 157-61.
19. Yaw PB, Sentany M, Link WJ, Wahle WM, Glover JL,. Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery? JAMA 1975; 231: 490-1.
20. Ward JF, Nowacki M, Sands JP, Conner RJ, Huisman TK,. Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. J Urol 1996; 156: 1381-4; discussion 4-5.
21. Stoffel JT, Topjian L, Libertino JA,. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int 2005; 96: 313-5.
22. Bouras I, Mingo O,. Should cell salvage be used in oncological surgery? Br J Hosp Med (Lond) 2010; 71: 57.
23. Nieder AM, Simon MA, Kim SS, Manoharan M, Soloway MS,. Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah's Witnesses. Int Braz J Urol 2004; 30: 377-9.
24. Waters JH, Yazer M, Chen Y, Kloke J,. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 2012; 52: 2167-73.